Cargando…

Is Fibrosis Really Fibrosis?

Detalles Bibliográficos
Autores principales:	Vijayakumar, Bavithra, Shah, Pallav L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456529/ https://www.ncbi.nlm.nih.gov/pubmed/33711245 http://dx.doi.org/10.1164/rccm.202102-0334LE

Ejemplares similares

Not All Parenchymal Changes on Computed Tomography Are Interstitial Lung Disease
por: Vijayakumar, Bavithra, et al.
Publicado: (2021)

When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients
por: Faro, Albert, et al.
Publicado: (2022)

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

Isoniazid and Pulmonary Fibrosis
por: Chung, Chae Uk, et al.
Publicado: (2015)

Is COVID in Neonates Really Mild?
por: Khamkar, Anilkumar M., et al.
Publicado: (2021)

Progressive Pulmonary Fibrosis: Putting the Cart Before the Horse
por: Johannson, Kerri A., et al.
Publicado: (2022)

Liver fibrosis and adverse outcomes in COVID-19
por: Huang, Jianmin
Publicado: (2021)

Postvaccination Acute Exacerbations of Idiopathic Pulmonary Fibrosis?
por: Huang, Jin-Xian, et al.
Publicado: (2022)

Novel Insight into Pulmonary Fibrosis and Long COVID
por: Kamp, Jan C., et al.
Publicado: (2023)

Does particle disease really exist?
por: Mjöberg, Bengt
Publicado: (2018)

Reply to: “Liver fibrosis and adverse outcomes in COVID-19”
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021)

Burkholderia cepacia complex in Indian cystic fibrosis patients
por: Gautam, Vikas, et al.
Publicado: (2012)

Diethylcarbamazine as potential treatment of COVID-19 lung fibrosis
por: Medina-De la Garza, Carlos Eduardo, et al.
Publicado: (2022)

Reply: Transitioning endothelial cells contribute to pulmonary fibrosis
por: Wu, Xiuju, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis and cancer: do they really look similar?
por: Vancheri, Carlo
Publicado: (2015)

CT Lung Abnormalities after COVID-19 at 3 Months and 1 Year after Hospital Discharge
por: Vijayakumar, Bavithra, et al.
Publicado: (2021)

Peripheral Blood Telomere Attrition in Persons at Risk for Familial Pulmonary Fibrosis
por: Salisbury, Margaret L., et al.
Publicado: (2022)

Lung fibrosis: an undervalued finding in COVID-19 pathological series
por: Grillo, Federica, et al.
Publicado: (2021)

Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France
por: Martin, Clémence, et al.
Publicado: (2021)

The Effects of the COVID-19 Pandemic on Pediatric Cystic Fibrosis Patients
por: Beşer, Ömer Faruk, et al.
Publicado: (2021)

Adrenal reserve in acute exacerbation of non-cystic fibrosis bronchiectasis
por: Rajagopala, Srinivas, et al.
Publicado: (2015)

Growth assessment and risk factors of malnutrition in children with cystic fibrosis
por: Al-Mendalawi, Mahmood D.
Publicado: (2016)

Comparing Transbronchial Cryobiopsy and Surgical Biopsy in Idiopathic Pulmonary Fibrosis
por: Quadrelli, Silvia, et al.
Publicado: (2019)

Lung Fibrosis Following Acute Covid-19 Infection in an Infant
por: Rokaiyya, Anis, et al.
Publicado: (2022)

Comments on COVID-19 Vaccination and Exacerbation of Idiopathic Pulmonary Fibrosis
por: Kang, Tianlun, et al.
Publicado: (2022)

Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?
por: Cottin, Vincent, et al.
Publicado: (2022)

Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
por: Rose, Jonathan A., et al.
Publicado: (2022)

COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
por: Sgalla, Giacomo, et al.
Publicado: (2022)

Radiolabeled fibroblast activation protein inhibitors in the evaluation of myocardial fibrosis
por: Su, Xiangyu, et al.
Publicado: (2023)

A role for CT in COVID-19? What data really tell us so far
por: Hope, Michael D, et al.
Publicado: (2020)

Care for Amish and Mennonite children with cystic fibrosis: a case series
por: Henderson, Jonathan F, et al.
Publicado: (2009)

Patient Registries in Idiopathic Pulmonary Fibrosis: Don't Forget Socioeconomic Status
por: Sesé, Lucile, et al.
Publicado: (2020)

Lower Airway Infection in Preschool Children with Cystic Fibrosis: An International Comparison
por: Hulme, Kathryn M., et al.
Publicado: (2020)

Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kobayashi, Tetsu, et al.
Publicado: (2020)

Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: a matter of control
por: Bellaye, Pierre-Simon, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis Update: Reconciliation with Hypersensitivity Pneumonitis Guidelines Required?
por: Moran-Mendoza, Onofre
Publicado: (2022)

Antifibrotics and Reduced Mortality in Idiopathic Pulmonary Fibrosis: Immortal Time Bias
por: Suissa, Samy, et al.
Publicado: (2022)

Patient Characteristics and Survival for Progressive Pulmonary Fibrosis Using Different Definitions
por: Khor, Yet H., et al.
Publicado: (2022)

Functional Criteria to Define Progressive Pulmonary Fibrosis: Searching for the Holy Grail
por: Noboa-Sevilla, María, et al.
Publicado: (2022)

Moving the Dial on Airway Inflammation in Response to Trikafta in Adolescents with Cystic Fibrosis
por: Lepissier, Agathe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6gf1ocpqc3ojil00ef7ub1a20o